动态脑[18F]氟雌二醇PET协议优化以提高乳腺癌脑转移检出
前瞻性纳入11例ER阳性乳腺癌脑转移患者,行动态[18F]FES PET/CT并同期增强脑MRI为参考标准,比较注射后四个15分钟时间窗的病灶匹配率与SUVR;注射后60-75分钟时间窗病灶匹配率最高(68%),但8个病灶在75-90分钟不可见,提示60-75分钟可能为最佳采集时间窗。
要点
- 注射后60-75分钟时间窗病灶匹配率最高,为68%(63/92个病灶)。
- 8个病灶在60-75分钟可见,但在75-90分钟不可见。
- SUVR随时间递增,但更晚时间点并未提高病灶检出。
核心结论
- 注射后60-75分钟时间窗为ER阳性乳腺癌及疑似脑转移患者脑[18F]FES PET提供最佳病灶匹配率,超过该间隔成像可能不进一步提高诊断率并可能降低可见性。
研究设计与样本
- 前瞻性研究,纳入11例ER阳性原发乳腺癌合并脑转移患者,行动态[18F]FES PET/CT(90分钟采集、34帧)及同期标准诊疗增强脑MRI,以MRI为参考标准进行病灶特征描述与分割并与PET共配准。
关键影像表现/征象
- MRI确认92个病灶,包括73个脑实质、8个软脑膜、6个颅骨、4个硬脑膜-based及1个垂体柄病灶。
- 注射后60-75分钟时间窗病灶匹配率最高,为68%(63/92个病灶)。
- 注射后45-60分钟时间窗病灶匹配率为62%,75-90分钟为60%,30-45分钟为57%。
- 平均SUVR随时间递增,时间窗1至4分别为1.83(SD 1.46)、2.08(SD 1.88)、2.29(SD 2.37)、2.38(SD 2.50)。
- 8个病灶(6个脑实质、1个软脑膜、1个颅骨)在60-75分钟可见,但在75-90分钟不可见。
诊断标准与关键数值
- 以同期增强脑MRI作为临床病灶特征描述与分割的参考标准。
- 病灶匹配率按时间窗计算,注射后60-75分钟为68%(63/92个病灶),为四个时间窗中最高。
- SUVR以小脑皮质为参考区归一化,随时间窗递增。
临床应用与阅片要点
- 作者认为注射后60-75分钟可能为脑[18F]FES PET的最佳采集时间窗。
- 作者强调时间标准化对脑[18F]FES PET神经肿瘤应用的重要性。
局限性
- 样本量小。
- 既往治疗方面人群存在异质性。
- 缺乏病理学确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Brain [18F] fluoroestradiol (FES) PET enables noninvasive assessment of estrogen receptor (ER) expression and may improve the detection of ER-positive (ER+) breast cancer brain metastases (BC-BM), with pilot studies demonstrating clinical utility. Our aim was to leverage our dynamic brain [18F] FES PET acquisition protocol to characterize BC-BM uptake kinetics across different postinjection intervals, with the goal of improving lesion detectability.
MATERIALS AND METHODS: Patients with ER+ primary disease and BC-BM were enrolled prospectively and underwent dynamic [18F] FES PET/CT and contemporaneous standard-of-care contrast-enhanced brain MRI. PET was acquired during 90 minutes using a dynamic protocol (34 frames). Four 15-minute static time windows were reconstructed, including 30-45, 45-60, 60-75, and 75-90 minutes after injection, respectively. MRI was used as the criterion standard for clinical lesion characterization and segmentation, with subsequent [18F] FES PET co-registration. The time window-specific PET MRI lesion matching rate (LMR) and mean standardized uptake value ratio (SUVR, normalized to cerebellar cortex) were calculated.
RESULTS: Eleven patients with a total of 92 MRI-confirmed lesions were included (73 parenchymal, 8 leptomeningeal, 6 calvarial, 4 dural-based, and 1 pituitary stalk). Time window-3 yielded the highest LMR at 68% (63/92 lesions), followed by time window-2 (62%), time window-4 (60%), and time window-1 (57%). The mean SUVR increased across time, with means of 1.83 (standard deviation [SD], 1.46), 2.08 (SD, 1.88), 2.29 (SD, 2.37), and 2.38 (SD, 2.50) for time window-1, -2, -3, and -4, respectively. Despite a higher SUVR at later time points, 8 lesions (6 parenchymal, 1 leptomeningeal, and 1 calvarial) that were visible at 60-75 minutes were undetectable at 75-90 minutes.
CONCLUSIONS: Time window-3 at 60-75 minutes after injection provided optimal LMR for brain [18F] FES PET in ER+ BC and suspected BM. Imaging beyond this interval may not further improve diagnostic yield and may reduce visibility. Limitations of this study include the small cohort size, population heterogeneity regarding prior treatment, and lack of pathologic confirmation. Our findings suggest that 60-75 minutes after injection may represent the optimal acquisition time window and highlight the importance of timing standardization for neuro-oncologic applications of brain [18F] FES PET.
引用
- Elmoujarkach E, Sharbatdaran A, Pontolillo L, et al. Dynamic Brain [18F] Fluoroestradiol PET Protocol Optimization for Improved Detection of Breast Cancer Brain Metastases. AJNR Am J Neuroradiol. 2026. PMID: 41887747. doi:10.3174/ajnr.A9316
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。